Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Rheumatology Therapeutics Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The rheumatology therapeutics market has seen steady expansion in recent years. It is projected to grow from $42.4 billion in 2024 to $44.18 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.2%. The historical increase in this market can be ascribed to the increasing prevalence of rheumatologic disorders, a globally expanding aging population, enhanced awareness concerning treatment options, progress in biological therapies, and the broader availability of healthcare services in emerging markets.

The rheumatology therapeutics market is expected to show sustained expansion in the coming years. It is forecast to grow to “$52.25 billion in 2029, achieving a compound annual growth rate (CAGR) of 4.3%.” This projected growth during the forecast period stems from various factors, including the increasing adoption of personalized medicine approaches, the rising use of biosimilars in rheumatology, augmented investment in research and development, the integration of digital health technologies, and regulatory approvals for innovative therapies. Significant trends anticipated in this period encompass the expansion of telemedicine and remote monitoring solutions, the development of more targeted therapies for specific rheumatic conditions, a heightened focus on patient-centric care models, the diversification of biologic treatments beyond monoclonal antibodies, and the implementation of value-based pricing models.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17246&type=smp

What Are The Key Drivers Of Growth In The Rheumatology Therapeutics Market?

The increasing occurrence of autoimmune conditions is anticipated to drive the expansion of the rheumatology therapeutics market in the future. An autoimmune disease refers to a state where the immune system erroneously targets and harms the body’s own tissues. The spread of autoimmune diseases is on the rise, attributed to a mix of genetic, environmental, and lifestyle elements, alongside heightened awareness and better diagnostic methods. Rheumatology treatments are essential for autoimmune diseases to control inflammation, ease symptoms, and stop the damage to joints and tissues resulting from the immune system’s assault on the body. For example, data from June 2024 by the Australian Institute of Health and Welfare, an Australia-based government body, estimated that approximately 514,000 individuals in Australia, representing 2.0% of the population, had rheumatoid arthritis in 2022. Rheumatoid arthritis constituted 2.0% of the total disease burden and 16% of the burden for all musculoskeletal conditions during 2023. Consequently, the growing incidence of autoimmune diseases is fueling the expansion of the rheumatology therapeutics market.

What Are The Key Segments In The Rheumatology Therapeutics Market?

The rheumatology therapeutics market covered in this report is segmented –

1) By Drug Class: Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By Disease Indication: Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, Ankylosing Spondylitis, Other Disease Indications

Subsegments:

1) By Disease Modifying Anti-Rheumatic Drugs (DMARDs): Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): COX-2 Inhibitors, Traditional NSAIDs

3) By Corticosteroids: Oral Corticosteroids, Injectable Corticosteroids, Topical Corticosteroids

4) By Uric Acid Drugs: Uric Acid Lowering Agents, Uricosuric Agents, Pegloticase

5) By Other Drug Classes: Immunosuppressants, Biologic Therapies, Analgesics

What Are The Major Trends Driving The Growth Of The Rheumatology Therapeutics Market?

Major companies within the rheumatology therapeutics market are developing innovative solutions, such as intravenous (IV) formulations, to enhance treatment efficacy and patient convenience. An intravenous (IV) formulation refers to a medication or substance administered directly into a vein through a needle or catheter. For instance, in October 2023, Novartis AG, a Switzerland-based pharmaceutical company, announced the US Food and Drug Administration (FDA) had approved Cosentyx, an intravenous (IV) formulation. This form of Cosentyx is uniquely approved to treat adults with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). It works by specifically targeting and inhibiting interleukin-17A (IL-17A) and is the only non-tumor necrosis factor alpha (TNF-a) IV treatment available for these conditions.

Who Are The Major Companies Operating In The Rheumatology Therapeutics Market?

Major companies operating in the rheumatology therapeutics market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Janssen Biotech, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals, UCB S.A., Galapagos NV (GLPG), Genentech Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Rheumatology Therapeutics Market?

North America was the largest region in the rheumatology therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rheumatology therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Rheumatology Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=17246&type=smp

Browse Through More Reports Similar to the Global Rheumatology Therapeutics Market 2025, By The Business Research Company

Rheumatoid Arthritis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report

Leukemia Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report

Bipolar Disorder Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.